Dr. Afshin Safavi

Dr. Safavi is a veteran biochemist with extensive experience establishing and leading bioanalytical teams in pharmaceutical, biotechnology, and manufacturing companies, as well as contract research organizations.  He and his teams have supported the development of a broad range of therapeutics in preclinical and clinical trial laboratories.  Prior to founding BioAgilytix Labs, he was the Director of Ligand Binding and Immunoassay, operating under GLP at AAIPharma.  At Talecris BioTherapeutics, he led the Preclinical and Clinical Assay Development team, building on his experience as a senior scientist at Nobex Corporation, GlaxoSmithKline and IGEN International.

Dr. Safavi is considered an expert in the area of immunoassays, with a wide working knowledge of various platforms.  He obtained his B.S. in Biochemistry from UCLA, his Ph.D. in Biochemistry from the University of Kentucky’s Medical School, (Department of Biochemistry), and he completed a two-year postdoctoral assignment at Emory University’s Department of Pathology.